🟢 Concentrix is trading 5% up in pre-market after sharp rebound following lowered 2026 guidance

Concentrix is trading 5.34% up at $29.00 after a sharp rebound following its recent fiscal-year guidance reduction.

• Coverage identifies the lowered 2026 adjusted EPS outlook of $10.83–$11.18 and revenue outlook of $9.93–$10.03 billion as the central investor issue.
• Third-quarter results are scheduled for September 29, 2026, potentially supporting renewed positioning.
• No fresh September 22 company announcement or analyst action was identified; the move appears primarily rebound-driven as broader markets were mixed pre-market.